Search bioRxiv⌕ Search

Biology subjects

Marinelli, M.

Publications and source records attributed to Marinelli, M..

2 recordsLinked to original sources

Interlocked transcription factor feedback loops maintain and restore touch sensation

The sense of touch relies on the continuous function of specialized mechanosensory circuits, but the underlying molecular mechanisms remain poorly understood. Here, we report that the conserved transcription factors (TFs) CFI-1 (ARID3) and EGL-5 (HOXA7) jointly maintain in adult C. elegans the molecular identity of two key interneuron types, securing information processing within a mechanosensory circuit. Toggling between normal and low levels of CFI-1 or EGL-5 in adults generated digital-like (ON/OFF) effects both on touch-evoked escape response and interneuron identity. Strikingly, reintroduction of CFI-1 following its prolonged depletion restored escape response defects. Mechanistically, we identified two network motifs, a double-positive CFI-1/EGL-5 feedback loop and positive CFI-1 autoregulation, which together "lock-in" the interneuron identity programs. We propose that these interlocked motifs not only maintain robust escape responses throughout life, but are also essential for the restorability of adult-onset touch defects. Altogether, this work illuminates the molecular principles that maintain adult neuron identity and circuit function, and offers biomedically relevant insights into the restorability of neuronal and behavioral defects caused by mutations or variation in TF-encoding genes.

developmental biology↗

A novel small molecule PKC epsilon inhibitor reduces hyperalgesia induced by paclitaxel or opioid withdrawal

Aggressive marketing and increased prescribing of opioids for treating pain have fueled a prominent increase in opioid use disorder. This acute public health problem has led to calls for the development of non-opioid alternatives to treat chronic pain. The enzyme protein kinase C epsilon (PKC{varepsilon}) plays an important role in nociceptor sensitization, in inflammatory and neuropathic pain. Here we investigated the effects of a novel small molecule that inhibits PKC{varepsilon} in a rodent model of chemotherapy-induced neuropathic pain produced by administration of the cancer chemotherapy, paclitaxel. Because transition of opioid-dependent individuals to a non-opioid pain medication can increase pain due to opioid withdrawal, we also investigated if the PKC{varepsilon} inhibitor alters features of opioid withdrawal and opioid self-administration. This novel PKC{varepsilon} inhibitor attenuated paclitaxel-induced hyperalgesia, reversed hyperalgesia produced by opioid withdrawal, and reduced somatic signs of opioid withdrawal. This PKC{varepsilon} inhibitor did not modify opioid self-administration, nor produce self-administration. These findings suggest that PKC{varepsilon} inhibition is an effective, non-addictive strategy to treat chemotherapy-induced neuropathic pain with the added benefit of limiting hyperalgesia due to opioid withdrawal, which could facilitate switching treatment of chronic pain, in opioid-dependent individuals.

neuroscience↗